On Friday, Larimar Therapeutics Inc (NASDAQ: LRMR) opened higher 13.79% from the last session, before settling in for the closing price of $4.28. Price fluctuations for LRMR have ranged from $1.61 to $9.50 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 50.78% over the last five years. Company’s average yearly earnings per share was noted -25.79% at the time writing. With a float of $48.59 million, this company’s outstanding shares have now reached $64.03 million.
Larimar Therapeutics Inc (LRMR) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Larimar Therapeutics Inc is 43.23%, while institutional ownership is 42.29%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,000,000. In this transaction Director of this company bought 9,375,000 shares at a rate of $3.20, taking the stock ownership to the 9,538,945 shares.
Larimar Therapeutics Inc (LRMR) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.24 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.37) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.74% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Check out the current performance indicators for Larimar Therapeutics Inc (LRMR). In the past quarter, the stock posted a quick ratio of 5.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.65 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Analysing the last 5-days average volume posted by the [Larimar Therapeutics Inc, LRMR], we can find that recorded value of 10.82 million was better than the volume posted last year of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 58.74%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 86.26%, which indicates a significant increase from 77.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was higher than the 0.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.94, while its 200-day Moving Average is $3.16. Now, the first resistance to watch is $5.07. This is followed by the second major resistance level at $5.28. The third major resistance level sits at $5.67. If the price goes on to break the first support level at $4.47, it is likely to go to the next support level at $4.08. Now, if the price goes above the second support level, the third support stands at $3.87.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
There are currently 82,778K shares outstanding in the company with a market cap of 416.83 million. Presently, the company’s annual sales total 0 K according to its annual income of -80,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -26,180 K.
